Technical Analysis for NVLN - Novelion Therapeutics Inc.

Grade Last Price % Change Price Change
grade F 0.97 -1.52% -0.02
NVLN closed down 1.52 percent on Friday, January 18, 2019, on 5 percent of normal volume. It ran into resistance at its 50 day moving average.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical NVLN trend table...

Date Alert Name Type % Chg
Jan 18 50 DMA Resistance Bearish 0.00%
Jan 18 20 DMA Support Bullish 0.00%
Jan 17 Crossed Above 20 DMA Bullish -1.52%
Jan 17 Narrow Range Bar Range Contraction -1.52%
Jan 17 Inside Day Range Contraction -1.52%
Jan 16 Fell Below 20 DMA Bearish 2.11%
Jan 16 Fell Below 50 DMA Bearish 2.11%
Jan 16 Expansion Pivot Sell Setup Bearish Swing Setup 2.11%
Jan 16 Wide Bands Range Expansion 2.11%
Jan 16 Upper Bollinger Band Touch Strength 2.11%

Older signals for NVLN ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Novelion Therapeutics Inc, formerly QLT Inc., is a Canada-based biopharmaceutical company. The Company is engaged in development of new standards of care for individuals living with rare diseases. The Company is focused on advancing its portfolio of rare disease therapies by investing in science and clinical development. The Company holds a portfolio of products through its subsidiary, Aegerion Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases. The Company's portfolio of products include MYALEPT and JUXTAPID. The Company is also developing zuretinol acetate for the treatment of inherited retinal disease caused by underlying mutations in RPE65 or LRAT genes.
Is NVLN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 5.87
52 Week Low 0.7
Average Volume 2,453,015
200-Day Moving Average 2.7707
50-Day Moving Average 1.0176
20-Day Moving Average 0.967
10-Day Moving Average 1.0115
Average True Range 0.1144
ADX 21.73
+DI 26.7041
-DI 18.2647
Chandelier Exit (Long, 3 ATRs ) 0.8068
Chandelier Exit (Short, 3 ATRs ) 1.1532000000000001
Upper Bollinger Band 1.111
Lower Bollinger Band 0.823
Percent B (%b) 0.51
BandWidth 29.782834
MACD Line -0.0095
MACD Signal Line -0.0166
MACD Histogram 0.0071
Fundamentals Value
Market Cap 18.09 Million
Num Shares 18.6 Million
EPS -5.12
Price-to-Earnings (P/E) Ratio -0.19
Price-to-Sales 1.11
Price-to-Book 1.08
PEG Ratio 0.13
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.06
Resistance 3 (R3) 1.07 1.04 1.05
Resistance 2 (R2) 1.04 1.02 1.04 1.04
Resistance 1 (R1) 1.01 1.01 1.00 1.00 1.03
Pivot Point 0.98 0.98 0.98 0.98 0.98
Support 1 (S1) 0.95 0.96 0.94 0.94 0.91
Support 2 (S2) 0.92 0.95 0.92 0.90
Support 3 (S3) 0.89 0.92 0.90
Support 4 (S4) 0.88